GlassScriptPhysician profile
Jeffrey H Glaze
NPI 1255389896
$98,415.02
in general payments reported to CMS, 2019-2025
18 companies · $21.49 in 2025
The $21.49 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $16K · 2021: $19K · 2022: $1,678 · 2023: $724 · 2024: $286 · 2025: $21.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $60,071.03 | 2019-2024 | Farxiga, Lokelma |
| Amgen INC. | $36,616.63 | 2019-2024 | Tavneos, Krystexxa |
| Alexion Pharmaceuticals, INC. | $275.24 | 2019-2023 | Soliris |
| Travere Therapeutics, INC. | $259.36 | 2022-2024 | |
| Akebia Therapeutics INC | $234.03 | 2019-2023 | Auryxia |
| Vifor Pharma, INC. | $221.43 | 2019-2023 | Veltassa |
| Fresenius USA Marketing, INC. | $138.80 | 2019-2025 | Velphoro, Velphoro, Korsuva |
| Bayer Healthcare Pharmaceuticals INC. | $88.20 | 2022-2024 | |
| Opko Pharmaceuticals, LLC | $84.45 | 2019-2021 | |
| Horizon Therapeutics Plc | $81.80 | 2023 | Krystexxa |
| Otsuka America Pharmaceutical, INC. | $70.60 | 2022-2024 | Jynarque |
| Calliditas Therapeutics US INC. | $59.98 | 2023-2024 | Tarpeyo |
| Aurinia Pharma U.S., INC. | $55.00 | 2021-2022 | |
| Glaxosmithkline, LLC. | $52.99 | 2021-2023 | Benlysta |
| Kyowa Kirin, INC. | $41.26 | 2023-2024 | Crysvita |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $25.15 | 2019 | |
| Baxter Healthcare | $19.63 | 2024 | Renal - Acute |
| Mallinckrodt Hospital Products INC. | $19.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Glaze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.